Prevatt Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.8M Hold
162,000
12.89% 2
2025
Q4
$44.2M Hold
162,000
12.8% 3
2025
Q3
$43.8M Hold
162,000
14.88% 2
2025
Q2
$44.7M Buy
162,000
+12,000
+8% +$3.26M 15.32% 2
2025
Q1
$39.8M Hold
150,000
13.1% 2
2024
Q4
$34.8M Hold
150,000
10.03% 3
2024
Q3
$33.1M Buy
150,000
+35,000
+30% +$7.24M 10.89% 3
2024
Q2
$22.6M Buy
115,000
+5,000
+5% +$1.03M 7.05% 10
2024
Q1
$23.7M Hold
110,000
7.99% 5
2023
Q4
$23.2M Buy
+110,000
New +$23.5M 8.56% 5

Other funds holding CME

Prevatt Capital's CME Position: Q1 2026 in Review

Prevatt Capital held its CME Group (CME) position steady in Q1 2026 at 162,000 shares worth $47.8M. The position accounts for 12.89% of the portfolio, ranked #2.

Prevatt Capital first reported a position in CME in Q4 2023 and has held it in 10 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Prevatt Capital held 162,000 shares of CME Group worth $47.8M as of Q1 2026.
  • Prevatt Capital left its CME Group share count unchanged in Q1 2026.
  • CME Group made up 12.89% of Prevatt Capital's portfolio in Q1 2026, its #2 holding.
  • Prevatt Capital first reported a position in CME Group in Q4 2023 and has held it in 10 quarters since.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Prevatt Capital's 13F filing for Q1 2026, filed 27 Apr 2026.